RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 123 filers reported holding RELMADA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $226,000 | +96.5% | 6,118 | +0.8% | 0.09% | +109.3% |
| Q2 2022 | $115,000 | -50.0% | 6,068 | -28.7% | 0.04% | -58.3% |
| Q1 2022 | $230,000 | +13.3% | 8,516 | -5.5% | 0.10% | +33.8% |
| Q4 2021 | $203,000 | +15.3% | 9,015 | +34.5% | 0.08% | 0.0% |
| Q3 2021 | $176,000 | -22.1% | 6,703 | -5.0% | 0.08% | -17.2% |
| Q2 2021 | $226,000 | -28.3% | 7,056 | -21.1% | 0.09% | -30.1% |
| Q1 2021 | $315,000 | +11.7% | 8,947 | +1.9% | 0.13% | +13.7% |
| Q4 2020 | $282,000 | +14.2% | 8,783 | +33.8% | 0.12% | -10.0% |
| Q3 2020 | $247,000 | -26.0% | 6,564 | -12.0% | 0.13% | -17.7% |
| Q2 2020 | $334,000 | – | 7,463 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,270,072 | $61,269,000 | 9.93% |
| GREAT POINT PARTNERS LLC | 790,000 | $21,322,000 | 5.15% |
| ACUTA CAPITAL PARTNERS, LLC | 342,000 | $9,231,000 | 4.31% |
| COWEN AND COMPANY, LLC | 1,164,361 | $31,426,000 | 3.02% |
| Altium Capital Management LP | 206,000 | $5,560,000 | 1.86% |
| BVF INC/IL | 1,647,400 | $44,463,000 | 1.78% |
| RTW INVESTMENTS, LP | 2,540,074 | $68,557,000 | 1.42% |
| Vivo Capital, LLC | 705,882 | $19,052,000 | 1.31% |
| RA Capital Management | 2,000,000 | $53,980,000 | 1.18% |
| SPHERA FUNDS MANAGEMENT LTD. | 291,252 | $7,861,000 | 1.11% |